State of Wisconsin Investment Board’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.33M | Sell |
84,067
-16,975
| -17% | -$470K | 0.01% | 1225 |
|
|
2025
Q1 | $2.24M | Sell |
101,042
-11,477
| -10% | -$255K | 0.01% | 1192 |
|
|
2024
Q4 | $2.23M | Sell |
112,519
-2,237
| -2% | -$44.2K | 0.01% | 1244 |
|
|
2024
Q3 | $2.87M | Sell |
114,756
-33,109
| -22% | -$827K | 0.01% | 1169 |
|
|
2024
Q2 | $2.76M | Buy |
147,865
+10,218
| +7% | +$191K | 0.01% | 1163 |
|
|
2024
Q1 | $2.72M | Buy |
137,647
+56,570
| +70% | +$1.12M | 0.01% | 1150 |
|
|
2023
Q4 | $1.42M | Buy |
81,077
+56,282
| +227% | +$987K | ﹤0.01% | 1302 |
|
|
2023
Q3 | $431K | Sell |
24,795
-2,724
| -10% | -$47.3K | ﹤0.01% | 1879 |
|
|
2023
Q2 | $387K | Sell |
27,519
-2,226
| -7% | -$31.3K | ﹤0.01% | 1900 |
|
|
2023
Q1 | $320K | Sell |
29,745
-425
| -1% | -$4.57K | ﹤0.01% | 2060 |
|
|
2022
Q4 | $452K | Buy |
30,170
+3,319
| +12% | +$49.7K | ﹤0.01% | 1932 |
|
|
2022
Q3 | $345K | Sell |
26,851
-1,652
| -6% | -$21.2K | ﹤0.01% | 2153 |
|
|
2022
Q2 | $276K | Buy |
28,503
+7,403
| +35% | +$71.7K | ﹤0.01% | 2356 |
|
|
2022
Q1 | $210K | Buy |
+21,100
| New | +$210K | ﹤0.01% | 2170 |
|
|
2021
Q2 | – | Sell |
-49,700
| Closed | -$920K | – | 2119 |
|
|
2021
Q1 | $920K | Sell |
49,700
-4,400
| -8% | -$81.4K | ﹤0.01% | 1391 |
|
|
2020
Q4 | $956K | Buy |
54,100
+2,100
| +4% | +$37.1K | ﹤0.01% | 1333 |
|
|
2020
Q3 | $797K | Buy |
52,000
+29,100
| +127% | +$446K | ﹤0.01% | 1337 |
|
|
2020
Q2 | $583K | Buy |
22,900
+1,400
| +7% | +$35.6K | ﹤0.01% | 1374 |
|
|
2020
Q1 | $333K | Buy |
+21,500
| New | +$333K | ﹤0.01% | 1455 |
|
|
2019
Q3 | – | Sell |
-17,300
| Closed | -$234K | – | 1565 |
|
|
2019
Q2 | $234K | Buy |
+17,300
| New | +$234K | ﹤0.01% | 1473 |
|